Nanobiotix S.A.
Status: Publicly traded
Direct answer
Nanobiotix S.A. is publicly traded on NASDAQ under the ticker NBTX.
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and...
Can you invest in Nanobiotix S.A.?
Yes. Nanobiotix S.A. is publicly traded on NASDAQ under the ticker NBTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nanobiotix S.A.
Detailed equity research is provided by MarketSnap.